Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. W.M. (W Martin) Smid


Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low- and middle-income countries

Plasma-based COVID-19 treatments in low- and meddle-income countries and the risk of transfusion-transmitted infections.

Quality Improvement in a small-scale Caribbean Blood Bank: the value of long-term collaboration and stepwise process approach.

Apheresis in developing countries around the World

Falseā€positive viral marker results in blood donors and their unintended consequences: P. Kiely, V.C. Hoad, E.M. Wood: P. Kiely, VC Hoad, EM Wood

Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop

Points to consider in the preparation and transfusion of COVID-19 convalescent plasma in low- and middle- income countries

Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety

Positive HBV-NAT in a blood donor 11 years after HBV vaccination

Lymphocyte subset abnormalities in multitransfused HIV-negative haemophilia A patients are not due to chronic hepatitis C virus infection

Read more